Randomized trial to assess the clinical utility of renal allograft monitoring by urine CXCL10 chemokine

1Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland

2Department of Pathology, University Hospital Basel, Basel, Switzerland

3Molecular Immune Regulation, Department of Biomedicine, University of Basel, Basel, Switzerland

4HLA-Diagnostics and Immunogenetics, Department of Laboratory Medicine, University Hospital Basel, Basel, Switzerland

aCorresponding Author: Stefan Schaub, MD, Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland, Tel: 0041 61 265 45 33, Fax: 0041 61 265 24 10, e-mail: [email protected], ORCID: 0000-0002-9170-1341

*contributed equally

This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

留言 (0)

沒有登入
gif